Categories: News

Virbac : Declaration of the number of shares and voting rights 10/2022

 

 

 

 

 

 

 

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

 

 

 

Information on the total number of voting rights and of shares representing the share capital

(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité

des Marchés Financiers)

 

 

 

 

Quotation place: Euronext Paris

Compartiment A

ISIN code: FR0000031577

 

Date Total number of shares representing the share capital Total number of voting rights
October, 31 2022 8 458 000 Gross total of voting rights : 12 765 861
Net total* of voting rights : 12 752 425

 

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

 

 

 

 

 

 

 

VIRBAC: Shaping the future of animal health

NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP

Corporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.com

Website: www.virbac.com

Attachment

Staff

Recent Posts

President Trump’s Cannabis Decision Is Coming – And Why MMJ International Holdings Wins Either Way

12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…

14 hours ago

Accelerating Patient Recruitment and Research Excellence: TrialWire® Supports Endpoints Clinical Trials Day NYC 2025

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…

20 hours ago

Genesis Healthcare Remains Committed to Securing Longterm Stability

The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…

20 hours ago

Extendicare Announces December 2025 Dividend of C$0.042 per Share

MARKHAM, Ontario, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:…

20 hours ago

Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and…

20 hours ago